SEC declares effective registration statement for Semper Paratus–Tevogen Bio merger; $1.2B equity value

Tevogen Bio Holdings Inc.

SEC declared effective the Form S-4 for the business combination between Semper Paratus (LGST) and Tevogen Bio.
Pro forma equity value of combined company attributable to Tevogen stockholders expected to be $1.2 billion.
Special meeting of Semper Paratus stockholders to approve the transaction; closing expected shortly after subject to approvals.
Post-closing combined company will be renamed Tevogen Bio Holdings Inc.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.